BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28731222)

  • 41. Understanding the immunological interactions of engineered nanomaterials: Role of the bio-corona.
    Fadeel B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1798. PubMed ID: 36416023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ecotoxicity test methods for engineered nanomaterials: practical experiences and recommendations from the bench.
    Handy RD; Cornelis G; Fernandes T; Tsyusko O; Decho A; Sabo-Attwood T; Metcalfe C; Steevens JA; Klaine SJ; Koelmans AA; Horne N
    Environ Toxicol Chem; 2012 Jan; 31(1):15-31. PubMed ID: 22002667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eco-corona formation on the nanomaterials in the aquatic systems lessens their toxic impact: A comprehensive review.
    Natarajan L; Jenifer MA; Mukherjee A
    Environ Res; 2021 Mar; 194():110669. PubMed ID: 33359698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Considering the forms of released engineered nanomaterials in probabilistic material flow analysis.
    Adam V; Caballero-Guzman A; Nowack B
    Environ Pollut; 2018 Dec; 243(Pt A):17-27. PubMed ID: 30170204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathophysiologic mechanisms of biomedical nanomaterials.
    Wang L; Chen C
    Toxicol Appl Pharmacol; 2016 May; 299():30-40. PubMed ID: 26827823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of the protein corona on nanomaterial immune response and targeting ability.
    Digiacomo L; Pozzi D; Palchetti S; Zingoni A; Caracciolo G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1615. PubMed ID: 32003104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exploiting the novel properties of protein coronas: emerging applications in nanomedicine.
    Hamad-Schifferli K
    Nanomedicine (Lond); 2015 May; 10(10):1663-74. PubMed ID: 26008198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM).
    Westmeier D; Stauber RH; Docter D
    Toxicol Appl Pharmacol; 2016 May; 299():53-7. PubMed ID: 26592323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Translating Current Bioanalytical Techniques for Studying Corona Activity.
    Wang C; Wang Z; Dong L
    Trends Biotechnol; 2018 Jul; 36(7):661-672. PubMed ID: 29709374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gold nanoparticle should understand protein corona for being a clinical nanomaterial.
    Charbgoo F; Nejabat M; Abnous K; Soltani F; Taghdisi SM; Alibolandi M; Thomas Shier W; Steele TWJ; Ramezani M
    J Control Release; 2018 Feb; 272():39-53. PubMed ID: 29305922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Property-Activity Relationship of Black Phosphorus at the Nano-Bio Interface: From Molecules to Organisms.
    Qu G; Xia T; Zhou W; Zhang X; Zhang H; Hu L; Shi J; Yu XF; Jiang G
    Chem Rev; 2020 Feb; 120(4):2288-2346. PubMed ID: 31971371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Possibilities and limitations of modeling environmental exposure to engineered nanomaterials by probabilistic material flow analysis.
    Gottschalk F; Sonderer T; Scholz RW; Nowack B
    Environ Toxicol Chem; 2010 May; 29(5):1036-48. PubMed ID: 20821538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MESOCOSM: A mesocosm database management system for environmental nanosafety.
    Ayadi A; Rose J; de Garidel-Thoron C; Hendren C; Wiesner MR; Auffan M
    NanoImpact; 2021 Jan; 21():100288. PubMed ID: 35559777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging well-tailored nanoparticulate delivery system based on in situ regulation of the protein corona.
    Li Z; Wang Y; Zhu J; Zhang Y; Zhang W; Zhou M; Luo C; Li Z; Cai B; Gui S; He Z; Sun J
    J Control Release; 2020 Apr; 320():1-18. PubMed ID: 31931050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Merging worlds of nanomaterials and biological environment: factors governing protein corona formation on nanoparticles and its biological consequences.
    Foroozandeh P; Aziz AA
    Nanoscale Res Lett; 2015; 10():221. PubMed ID: 25995715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The nanoparticle biomolecule corona: lessons learned - challenge accepted?
    Docter D; Westmeier D; Markiewicz M; Stolte S; Knauer SK; Stauber RH
    Chem Soc Rev; 2015 Oct; 44(17):6094-121. PubMed ID: 26065524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advanced nuclear analytical and related techniques for the growing challenges in nanotoxicology.
    Chen C; Li YF; Qu Y; Chai Z; Zhao Y
    Chem Soc Rev; 2013 Nov; 42(21):8266-303. PubMed ID: 23868609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanomaterials: impact on cells and cell organelles.
    Krpetić Z; Anguissola S; Garry D; Kelly PM; Dawson KA
    Adv Exp Med Biol; 2014; 811():135-56. PubMed ID: 24683031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring 'new' bioactivities of polymers at the nano-bio interface.
    Wang C; Dong L
    Trends Biotechnol; 2015 Jan; 33(1):10-4. PubMed ID: 25441258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A nano-bio interfacial protein corona on silica nanoparticle.
    Zhang H; Peng J; Li X; Liu S; Hu Z; Xu G; Wu R
    Colloids Surf B Biointerfaces; 2018 Jul; 167():220-228. PubMed ID: 29656205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.